Home Infusion Therapy Market Analysis By Product (Infusion Pumps, IV Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infectives, Endocrinology, Hydration Therapy, Parenteral Nutrition), And Segment Forecasts, 2013 - 2024

  • ID: 4031925
  • Report
  • 100 pages
  • Grand View Research
1 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter Inc.
  • CareFusion Corporation
  • Fresenius Kabi
  • ICU Medical Inc.
  • JMS Co. Ltd.
  • MORE
The global home infusion therapy market is expected to be USD 28.3 billion by 2024. Increasing need to contain the soaring healthcare costs has led to a higher preference for home infusion therapies amongst patients requiring long-term care.

The growing healthcare expenditure level is a key concern amongst patients and governments worldwide, necessitating the implementation of effective measures to curb these costs. Hence, the home healthcare option serves as a cost-effective alternative to expensive hospital stays, which is expected to serve this market as a high impact rendering driver throughout the forecast period. Moreover, increasing awareness about the high prevalence of hospital-acquired infections is anticipated to accentuate the importance of home healthcare.

Currently, the major chronic diseases, such as cancer, diabetes, respiratory disorders, cardiovascular diseases, and other life threatening diseases, account for 60% of the total death count and 43% of the global disease burden. The administration of medication in the home setting provides several advantages to patients, which include faster recovery, greater comfort, fewer complications, cost savings, and others. This is expected to drive the growth of the market in the near future.

Further Key Findings From The Study Suggest:

The product segment was dominated by infusion pumps with a market share of around 45.0% in 2015 owing to the greater number of initiatives conducted by the key players pertaining to new product development.

Needleless connectors are projected to witness the highest CAGR over the forecast period owing to greater benefits associated with their use in comparison to needle connectors.

Anti-infectives segment contributed to the largest market revenue in 2015. This is mainly due to the fact that it is frequently employed for patients in homecare settings.

Chemotherapy segment is anticipated to exhibit the highest CAGR of over 9.0% over the forecast period, which is attributable to technological advancements that render their usage convenient.

Use of injectable drug therapy in endocrinology is also estimated to gain lucrative growth over the forecast period owing to increasing awareness levels of insulin pumps among patients and healthcare providers.

North America dominated the market in 2015 with revenue of around USD 5.0 billion. Rising government programs and initiatives to promote awareness pertaining to the benefits of home infusion therapy have resulted in the higher revenue generation in this region

Strategic collaborations, regional expansion efforts, and mergers and acquisitions are some of the foremost strategies adopted by the key players. For instance, in January 2014, Terumo Corporation signed an eight-year agreement to collaboratively market, distribute, and co-brand their peripheral I.V. catheter series with CareFusion Corporation.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter Inc.
  • CareFusion Corporation
  • Fresenius Kabi
  • ICU Medical Inc.
  • JMS Co. Ltd.
  • MORE
1 Research Methodology & Scope
1.1 Information procurement
1.1.1 Purchased database:
1.1.2 Internal Database
1.2 Research Methodology
1.3 Geographic Scope & Assumptions
1.4 Region Wise Market Calculation
1.4.1 Region Wise Market: Base Estimates
1.4.2 Global Market: CAGR Calculation
1.5 Region-based segment share calculation
1.6 List of Secondary Sources

2 Executive Summary
2.1 Market Snapshot

3 Home Infusion Therapy Industry Outlook
3.1 Market Segmentation
3.2 Market size and growth prospects
3.3 Home infusion therapy Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Growing geriatric population base
3.3.1.2 Rising prevalence of chronic disorders
3.3.1.3 Rapid technological advancements
3.3.1.4 Growing incidence of hospital acquired infections
3.3.1.5 Home healthcare as cost effective alternative
3.3.2 Market restraint analysis
3.3.2.1 Presence of complicated reimbursement framework and reimbursement cuts
3.4 Key Opportunities Prioritized
3.5 Industry Analysis Porter’s
3.6 Home Infusion Therapy PESTEL Analysis

4 Home Infusion Therapy Market: Product Estimates & Trend Analysis
4.1 Home infusion therapy market share by product, 2015& 2024
4.2 Infusion pumps
4.2.1 Infusion pumps market, 2013 - 2024 (USD Million)
4.3 Intravenous Sets
4.3.1. Intravenous sets market, 2013 - 2024 (USD Million)
4.4 IV cannulas
4.4.1. IV cannulas market, 2013 - 2024 (USD Million)
4.5 Needleless connectors
4.5.1. Needleless connectors market, 2013 - 2024 (USD Million)

5 Home Infusion Therapy Market: Application Estimates & Trend Analysis
5.1 Home infusion therapy market share by application, 2015 & 2024
5.2 Anti-Infective
5.2.1. Anti-Infective market, 2013 - 2024 (USD Million)
5.3 Endocrinology
5.3.1. Endocrinology market, 2013 - 2024 (USD Million)
5.4 Hydration Therapy
5.4.1. Hydration therapy market, 2013 - 2024 (USD Million)
5.5 Chemotherapy
5.5.1. Chemotherapy market, 2013 - 2024 (USD Million)
5.6 Enteral Nutrition
5.6.1. Enteral nutrition market, 2013 - 2024 (USD Million)
5.7 Parenteral Nutrition
5.7.1. Parenteral nutrition market, 2013 - 2024 (USD Million)
5.8 Specialty Pharmaceuticals
5.8.1 Specialty pharmaceuticals market, 2013 - 2024 (USD Million)
5.9 Others
5.9.1 Others market, 2013 - 2024 (USD Million)

6 Home Infusion Therapy Market: Regional Outlook
6.1 Home infusion therapy market share, by region, 2015 & 2024
6.2 North America
6.2.1 North America home infusion therapy market estimates and forecasts, 2013 - 2024
6.2.2 U.S.
6.2.3 U.S. home infusion therapy market estimates and forecasts, 2013 - 2024
6.2.4 Canada
6.2.5 Canada home infusion therapy market estimates and forecasts, 2013 - 2024
6.3 Europe
6.3.1 Europe home infusion therapy market estimates and forecasts, 2013 - 2024
6.3.2 Germany
6.3.3 Germany home infusion therapy market estimates and forecasts, 2013 - 2024
6.3.4 UK
6.3.5 UK home infusion therapy market estimates and forecasts, 2013 - 2024
6.4 Asia Pacific
6.4.1 Asia Pacific home infusion therapy market estimates and forecasts2013 - 2024
6.4.2 Japan
6.4.3 Japan home infusion therapy market estimates and forecasts, 2013 - 2024
6.4.4 China
6.4.5 China home infusion therapy market estimates and forecasts, 2013 - 2024
6.5 Latin America
6.5.1 Latin America home infusion therapy market estimates and forecasts, 2013 - 2024
6.5.2 Brazil
6.5.3 Brazil home infusion therapy market estimates and forecasts, 2013 - 2024
6.5.4 Mexico
6.5.5 Mexico home infusion therapy market estimates and forecasts, 2013 - 2024
6.6 Middle East and Africa
6.6.1 Middle East and Africa home infusion therapy market estimates and forecasts, 2013 - 2024 (USD Million)
6.6.2 South Africa
6.6.3 South Africa home infusion therapy market estimates and forecasts, 2013 - 2024

7 Competitive Landscape
7.1 B. Braun Melsungen AG
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Baxter Inc.
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 Caesarea Medical Electronics
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 CareFusion Corporation
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Fresenius Kabi
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 ICU Medical Inc.
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 JMS Co. Ltd.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Smiths Medical
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Terumo Corporation
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives

List of Tables

Table 1 Country share estimation
Table 2 Home Infusion Therapy - Key market driver analysis
Table 3 Home Infusion Therapy - Key market restraint analysis
Table 4 North America home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 5 North America home infusion therapy market, by application, 2013 - 2024 (USD Million)
Table 6 U.S. home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 7 U.S. home infusion therapy market, by application, 2013 - 2024 (USD Million)
Table 8 Canada home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 9 Canada home infusion therapy market, by application, 2013 - 2024 (USD Million)
Table 10 Europe home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 11 Europe home infusion therapy market, by application, 2013 - 2024 (USD Million)
Table 12 Germany home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 13 Germany home infusion therapy market, by application, 2013 - 2024 (USD Million)
Table 14 UK home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 15 UK home infusion therapy market, by application, 2013 - 2024 (USD Million)
Table 16 Asia Pacific home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 17 Asia Pacific home infusion therapy market, by application, 2013 - 2024 (USD Million)
Table 18 Japan home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 19 Japan home infusion therapy market, by application, 2013 - 2024 (USD Million)
Table 20 China home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 21 China home infusion therapy market, by application, 2013 - 2024 (USD Million)
Table 22 Latin America home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 23 Latin America home infusion therapy market, by application, 2013 - 2024 (USD Million)
Table 24 Brazil home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 25 Brazil home infusion therapy market, by application, 2013 - 2024 (USD Million)
Table 26 Mexico home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 27 Mexico home infusion therapy market, by application, 2013 - 2024 (USD Million)
Table 28 MEA home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 29 Middle East and Africa home infusion therapy market, by application, 2013 - 2024 (USD Million)
TAsBLE 30 South Africa home infusion therapy market, by product, 2013 - 2024 (USD Million)
Table 31 South Africa home infusion therapy market, by application, 2013 - 2024 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Market summary
Figure 4 Home Infusion Therapy: Market Segmentation
Figure 5 Home infusion therapy market revenue, (USD Million), 2013-2024
Figure 6 Home Infusion: Market Dynamics
Figure 7 Key Opportunities Prioritized
Figure 8 Home infusion therapy Porter’s analysis
Figure 9 Home infusion therapy - PESTEL analysis
Figure 10 Global home infusion therapy market share, by product, 2015 & 2024
Figure 11 Infusion pumps market, 2013 - 2024 (USD Million)
Figure 12 Intravenous sets market, 2013 - 2024 (USD Million)
Figure 13 IV cannulas market, 2013 - 2024 (USD Million)
Figure 14 Needleless connectors market, 2013 - 2024 (USD Million)
Figure 15 Global home infusion therapy market share, by application, 2015 & 2024
Figure 16 Anti-Infective market, 2013 - 2024 (USD Million)
Figure 17 Endocrinology market, 2013 - 2024 (USD Million)
Figure 18 Hydration therapy market, 2013 - 2024 (USD Million)
Figure 19 Chemotherapy market, 2013 - 2024 (USD Million)
Figure 20 Enteral nutrition market, 2013 - 2024 (USD Million)
Figure 21 Parenteral nutrition market, 2013 - 2024 (USD Million)
Figure 22 Specialty pharmaceuticals market, 2013 - 2024 (USD Million)
Figure 23 Others market, 2013 - 2024 (USD Million)
Figure 24 Home infusion therapy market share, by region, 2015 & 2024
Figure 25 North America home infusion therapy market, by application, 2013 - 2024 (USD Million)
Figure 26 U.S. home infusion therapy market, by application, 2013 - 2024 (USD Million)
Figure 27 Canada home infusion therapy market, by application, 2013 - 2024 (USD Million)
Figure 28 Europe home infusion therapy market, by application, 2013 - 2024 (USD Million)
Figure 29 Germany home infusion therapy market, 2013 - 2024 (USD Million)
Figure 30 UK home infusion therapy market,2013 - 2024 (USD Million)
Figure 31 Asia Pacific home infusion therapy market,,2013 - 2024 (USD Million)
Figure 32 Japan home infusion therapy market, 2013 - 2024 (USD Million)
Figure 33 China home infusion therapy market, by application, 2013 - 2024 (USD Million)
Figure 34 Latin America home infusion therapy market, by application, 2013 - 2024 (USD Million)
Figure 35 Brazil home infusion therapy market, by application, 2013 - 2024 (USD Million)
Figure 36 Mexico home infusion therapy market, by application, 2013 - 2024 (USD Million)
Figure 37 Middle East and Africa home infusion therapy market, by application, 2013 - 2024 (USD Million)
Figure 38 South Africa home infusion therapy market, by application, 2013 - 2024 (USD Million)
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • B. Braun Melsungen AG
  • Baxter Inc.
  • Caesarea Medical Electronics
  • CareFusion Corporation
  • Fresenius Kabi
  • ICU Medical Inc.
  • JMS Co. Ltd.
  • Smiths Medical
  • Terumo Corporation
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll